DiaSorin (OTCMKTS:DSRLF) Trading Down 5% – What’s Next?

DiaSorin S.p.A. (OTCMKTS:DSRLF)’s share price fell 5% during trading on Tuesday . The company traded as low as $79.05 and last traded at $79.05. 100 shares changed hands during mid-day trading, The stock had previously closed at $83.17.

Analyst Upgrades and Downgrades

DSRLF has been the topic of a number of research analyst reports. BNP Paribas Exane raised shares of DiaSorin to a “neutral” rating in a research note on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of DiaSorin in a research report on Tuesday, February 10th. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

DiaSorin Trading Down 5.0%

The company has a fifty day moving average price of $79.23 and a two-hundred day moving average price of $86.60.

DiaSorin Company Profile

DiaSorin S.p.A. is an Italy‐based global biotechnology company specializing in the development, manufacture and marketing of in vitro diagnostic products. Headquartered in Saluggia, DiaSorin serves clinical laboratories, hospitals and physician offices with a broad portfolio of immunodiagnostic assays and molecular diagnostic tests. The company’s shares trade on the Milan Stock Exchange and are available in the United States as over‐the‐counter (OTC) securities under the symbol DSRLF.

At the core of DiaSorin’s business are immunodiagnostic systems that measure antibodies, antigens and hormones in human samples.